Technical Analysis for NBSE - NeuBase Therapeutics, Inc.

Grade Last Price % Change Price Change
C 8.82 1.61% 0.14
NBSE closed up 1.61 percent on Friday, March 5, 2021, on 74 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 24
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical NBSE trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 1.61%
200 DMA Support Bullish 1.61%
Wide Bands Range Expansion 1.61%
Down 3 Days in a Row Weakness 1.61%
Lower Bollinger Band Touch Weakness 1.61%
Older End-of-Day Signals for NBSE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 2 days ago
Up 3% 2 days ago
200 DMA Support 2 days ago
Down 3% 2 days ago
Down 2 % 2 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NeuBase Therapeutics, Inc., a biotechnology company, engages in the development of various antisense therapies to address genetic diseases in the United States. The company offers gene silencing therapies, including the proprietary PATrOL platform, a peptide-nucleic acid antisense oligonucleotide for genetic diseases caused by mutant proteins, including the Huntington's disease and myotonic dystrophy, as well as various other genetic disorders. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Acid Gene Expression Genetic Disease Dystrophy Genetic Diseases Oligonucleotide Huntington's Disease DNA Genetic Disorder RNA Genetic Disorders Nucleic Acids Gene Silencing Myotonic Dystrophy

Is NBSE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.89
52 Week Low 4.523
Average Volume 314,116
200-Day Moving Average 8.51
50-Day Moving Average 9.12
20-Day Moving Average 10.47
10-Day Moving Average 9.55
Average True Range 0.80
ADX 27.6
+DI 19.30
-DI 30.24
Chandelier Exit (Long, 3 ATRs ) 10.49
Chandelier Exit (Short, 3 ATRs ) 10.69
Upper Bollinger Band 12.61
Lower Bollinger Band 8.33
Percent B (%b) 0.11
BandWidth 40.86
MACD Line -0.16
MACD Signal Line 0.16
MACD Histogram -0.3217
Fundamentals Value
Market Cap 203.94 Million
Num Shares 23.1 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -72.30
Price-to-Sales 0.00
Price-to-Book 5.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.90
Resistance 3 (R3) 9.84 9.43 9.72
Resistance 2 (R2) 9.43 9.15 9.46 9.66
Resistance 1 (R1) 9.12 8.98 9.28 9.18 9.60
Pivot Point 8.71 8.71 8.78 8.74 8.71
Support 1 (S1) 8.40 8.43 8.56 8.46 8.04
Support 2 (S2) 7.99 8.26 8.02 7.98
Support 3 (S3) 7.68 7.99 7.92
Support 4 (S4) 7.74